Today's 10.3% lift in the Neurotech International share price reflects more than the stock's compelling DOLCE in vitro test credentials.
Here's a chart comparing the ACI/Australian Cannabis Index of 16 stocks (excluding NTI) with the Toronto-based HMMJ/Horizons Marijuana Life Sciences Index ETF.
Clearly, there's surging momentum for "pot stocks" in Canada...and in Australia.
I'm glad that NTI is now embedded in the medicinal cannabis space.
3c M/C $18m going to 20c M/C $120m in 150 days, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.8¢ |
Change
-0.001(5.26%) |
Mkt cap ! $18.89M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.7¢ | $5.133K | 289.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 507969 | 1.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.8¢ | 116381 | 2 |
View Market Depth
| Last trade - 16.10pm 11/07/2025 (20 minute delay) ? |
| NTI (ASX) Chart |